HQL
Tekla Life Sciences Investors
NYSE · Financial Services · Asset Management · US
$20.64
−0.34%Margins
Gross margin
89.9%
EBITDA margin
233.0%
EBIT margin
187.5%
Net margin
233.0%
FCF margin
-2.9%
33.2%
Return on equity
33.0%
Return on assets
26.7%
Return on invested capital
0.15x
Asset turnover
-$2.3M
Cash from operations
$0.03
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026